Most 'Emergency' Transfers for Plastic Surgery Evaluation Are Unnecessary
Patients with hand or facial injuries seen in the emergency department (ED) are commonly transferred to a trauma center for "emergency" evaluation by a plastic surgeon. But nearly three-fourths of those transfers are unnecessary, reports a study in the June issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
"We found that less than one-third of patients required [emergency] transfer for evaluation by a plastic surgeon, and almost half did not receive an [acute] intervention following transfer," write Dr. Brian C. Drolet of Johns Hopkins, Baltimore, and colleagues. They discuss steps that might help to avoid the unnecessary costs, delays, and risks of these inappropriate hospital transfers.
No Need for Emergency Plastic Surgery Evaluation in Many Cases
The researchers evaluated the frequency and impact of emergency transfers to Rhode Island Hospital—the only level I trauma center in that state—for plastic surgery evaluation of hand and facial injuries. A review of more than 32,000 ED encounters between 2009 and 2013 identified nearly 1,200 patients sent for emergency evaluation of trauma to the hand or face.
Dr. Drolet and colleagues evaluated the necessity of each emergency transfer, based on the resources available at the original center and the treatment actually provided at the trauma center. Most patients were transferred from other hospital emergency departments—even though many of these hospitals had full-time on-call coverage for facial and hand surgery.
On independent review, nearly three-quarters of the transfers were considered unnecessary—the patients could have been treated at the original hospital, or sent home from the ED with a referral for follow-up by a plastic surgeon.
Only about ten percent of transferred patients were admitted to the plastic surgery service at Rhode Island Hospital and underwent non-emergency surgery. Overall, just 30 patients—2.5 percent of the total—required emergency surgery.
Hospital charges for patients with unnecessary transfers averaged about $5,400, for a total expense of nearly $4.6 million. Transfer was associated with delays in definitive care; on average, it was nearly seven hours before the patients were finally sent home or admitted to the hospital.
Nearly 60 percent of transferred patients did not have private health insurance. Patients with less- favorable insurance status (eg, public insurance) or no insurance were more likely to be unnecessarily transferred. This raises concern about possible "patient dumping"—transferring patients to other hospitals because of inability to pay or inconvenience to healthcare providers.
Many patients with hand or face trauma do need to be evaluated by plastic surgeons, who have special expertise in treatment and reconstruction of hand and facial injuries. However, there are no standardized guidelines for emergency transfer of patients with isolated hand or facial injuries.
This creates "a frustrating and expensive problem for patients and the healthcare system," Dr. Drolet and colleagues write. "Patients who are transferred unnecessarily experience a delay in definitive care," in addition to excess costs from transportation, duplicated tests, and so forth.
The study adds new evidence on the high rate of unnecessary hospital transfers for plastic surgery evaluation. The researchers highlight the need for steps to reduce unnecessary transfers—perhaps involving conversations between the transferring provider and the surgeon on call at the trauma center.
They also call for further studies to develop guidelines for appropriate emergency transfer—based on the resources available at the original hospital and the treatment provided at the receiving hospital. Dr. Drolet and coauthors conclude, "Ultimately, the entire community of plastic surgeons and our patients, as well the healthcare system, will benefit from improved care of patients in the emergency setting."
Click here to read "Unnecessary Emergency Transfers for Evaluation by a Plastic Surgeon: A Burden to Patients and the Health Care System.”
Article: "Unnecessary Emergency Transfers for Evaluation by a Plastic Surgeon: A Burden to Patients and the Health Care System.” (doi: 10.1097/PRS.0000000000002147)
About Plastic and Reconstructive Surgery
For over 75 years, Plastic and Reconstructive Surgery® has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair and cosmetic surgery, as well as news on medico-legal issues.
The American Society of Plastic Surgeons (ASPS) is the largest organization of board-certified plastic surgeons in the world. Representing more than 11,000 physician members worldwide, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 92 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions and services for the clinicians, nurses, accountants, lawyers and tax, finance, audit, risk, compliance and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.